Travelers Vaccines Industry Research Report 2024

Travelers Vaccines Industry Research Report 2024


A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and remember it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Highlights

The global Travelers Vaccines market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Travelers Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Travelers Vaccines.
The Travelers Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Travelers Vaccines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Travelers Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai

Product Type Insights

Global markets are presented by Travelers Vaccines type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Travelers Vaccines are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Travelers Vaccines segment by Type

Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Travelers Vaccines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Travelers Vaccines market.
Travelers Vaccines segment by End Users
Tourists
Students
Workers
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Travelers Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Travelers Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Travelers Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Travelers Vaccines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Travelers Vaccines.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Travelers Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Travelers Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Travelers Vaccines Market Size (2019-2030) & (US$ Million)
2.2.2 Global Travelers Vaccines Sales (2019-2030)
2.2.3 Global Travelers Vaccines Market Average Price (2019-2030)
2.3 Travelers Vaccines by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
2.4 Travelers Vaccines by End Users
2.4.1 Market Value Comparison by End Users (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Tourists
2.4.3 Students
2.4.4 Workers
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Travelers Vaccines Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Travelers Vaccines Sales (K Doses) of Manufacturers (2019-2024)
3.3 Global Travelers Vaccines Revenue of Manufacturers (2019-2024)
3.4 Global Travelers Vaccines Average Price by Manufacturers (2019-2024)
3.5 Global Travelers Vaccines Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Travelers Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Travelers Vaccines, Product Type & Application
3.8 Global Manufacturers of Travelers Vaccines, Date of Enter into This Industry
3.9 Global Travelers Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 GlaxoSmithKline
4.1.1 GlaxoSmithKline Company Information
4.1.2 GlaxoSmithKline Business Overview
4.1.3 GlaxoSmithKline Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
4.1.5 GlaxoSmithKline Recent Developments
4.2 Sanofi Pasteur
4.2.1 Sanofi Pasteur Company Information
4.2.2 Sanofi Pasteur Business Overview
4.2.3 Sanofi Pasteur Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
4.2.5 Sanofi Pasteur Recent Developments
4.3 Merck
4.3.1 Merck Company Information
4.3.2 Merck Business Overview
4.3.3 Merck Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Merck Travelers Vaccines Product Portfolio
4.3.5 Merck Recent Developments
4.4 Pfizer
4.4.1 Pfizer Company Information
4.4.2 Pfizer Business Overview
4.4.3 Pfizer Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Pfizer Travelers Vaccines Product Portfolio
4.4.5 Pfizer Recent Developments
4.5 CNBG
4.5.1 CNBG Company Information
4.5.2 CNBG Business Overview
4.5.3 CNBG Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.5.4 CNBG Travelers Vaccines Product Portfolio
4.5.5 CNBG Recent Developments
4.6 Sanofi Pasteur MSD
4.6.1 Sanofi Pasteur MSD Company Information
4.6.2 Sanofi Pasteur MSD Business Overview
4.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
4.6.5 Sanofi Pasteur MSD Recent Developments
4.7 Serum Institute of India
4.7.1 Serum Institute of India Company Information
4.7.2 Serum Institute of India Business Overview
4.7.3 Serum Institute of India Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Serum Institute of India Travelers Vaccines Product Portfolio
4.7.5 Serum Institute of India Recent Developments
4.8 Biokangtai
4.8.1 Biokangtai Company Information
4.8.2 Biokangtai Business Overview
4.8.3 Biokangtai Travelers Vaccines Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Biokangtai Travelers Vaccines Product Portfolio
4.8.5 Biokangtai Recent Developments
5 Global Travelers Vaccines Market Scenario by Region
5.1 Global Travelers Vaccines Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Travelers Vaccines Sales by Region: 2019-2030
5.2.1 Global Travelers Vaccines Sales by Region: 2019-2024
5.2.2 Global Travelers Vaccines Sales by Region: 2025-2030
5.3 Global Travelers Vaccines Revenue by Region: 2019-2030
5.3.1 Global Travelers Vaccines Revenue by Region: 2019-2024
5.3.2 Global Travelers Vaccines Revenue by Region: 2025-2030
5.4 North America Travelers Vaccines Market Facts & Figures by Country
5.4.1 North America Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Travelers Vaccines Sales by Country (2019-2030)
5.4.3 North America Travelers Vaccines Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Travelers Vaccines Market Facts & Figures by Country
5.5.1 Europe Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Travelers Vaccines Sales by Country (2019-2030)
5.5.3 Europe Travelers Vaccines Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Travelers Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Travelers Vaccines Sales by Country (2019-2030)
5.6.3 Asia Pacific Travelers Vaccines Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Travelers Vaccines Market Facts & Figures by Country
5.7.1 Latin America Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Travelers Vaccines Sales by Country (2019-2030)
5.7.3 Latin America Travelers Vaccines Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.7.7 Colombia
5.8 Middle East and Africa Travelers Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa Travelers Vaccines Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Travelers Vaccines Sales by Country (2019-2030)
5.8.3 Middle East and Africa Travelers Vaccines Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Travelers Vaccines Sales by Type (2019-2030)
6.1.1 Global Travelers Vaccines Sales by Type (2019-2030) & (K Doses)
6.1.2 Global Travelers Vaccines Sales Market Share by Type (2019-2030)
6.2 Global Travelers Vaccines Revenue by Type (2019-2030)
6.2.1 Global Travelers Vaccines Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Travelers Vaccines Revenue Market Share by Type (2019-2030)
6.3 Global Travelers Vaccines Price by Type (2019-2030)
7 Segment by End Users
7.1 Global Travelers Vaccines Sales by End Users (2019-2030)
7.1.1 Global Travelers Vaccines Sales by End Users (2019-2030) & (K Doses)
7.1.2 Global Travelers Vaccines Sales Market Share by End Users (2019-2030)
7.2 Global Travelers Vaccines Revenue by End Users (2019-2030)
6.2.1 Global Travelers Vaccines Sales by End Users (2019-2030) & (US$ Million)
6.2.2 Global Travelers Vaccines Revenue Market Share by End Users (2019-2030)
7.3 Global Travelers Vaccines Price by End Users (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Travelers Vaccines Value Chain Analysis
8.1.1 Travelers Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Travelers Vaccines Production Mode & Process
8.2 Travelers Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Travelers Vaccines Distributors
8.2.3 Travelers Vaccines Customers
9 Global Travelers Vaccines Analyzing Market Dynamics
9.1 Travelers Vaccines Industry Trends
9.2 Travelers Vaccines Industry Drivers
9.3 Travelers Vaccines Industry Opportunities and Challenges
9.4 Travelers Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings